- Home
- EYPT vs ASIX Comparison
EYPT vs ASIX Comparison
Compare EYPT & ASIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYPT
- ASIX
- Stock Information
- Founded
- EYPT 1987
- ASIX 2016
- Country
- EYPT United States
- ASIX United States
- Employees
- EYPT N/A
- ASIX N/A
- Industry
- EYPT Biotechnology: Laboratory Analytical Instruments
- ASIX Major Chemicals
- Sector
- EYPT Industrials
- ASIX Industrials
- Exchange
- EYPT Nasdaq
- ASIX Nasdaq
- Market Cap
- EYPT 579.4M
- ASIX 654.2M
- IPO Year
- EYPT 2005
- ASIX N/A
- Fundamental
- Price
- EYPT $10.48
- ASIX $21.93
- Analyst Decision
- EYPT Strong Buy
- ASIX Buy
- Analyst Count
- EYPT 8
- ASIX 1
- Target Price
- EYPT $24.75
- ASIX $32.00
- AVG Volume (30 Days)
- EYPT 729.0K
- ASIX 221.8K
- Earning Date
- EYPT 08-06-2025
- ASIX 08-01-2025
- Dividend Yield
- EYPT N/A
- ASIX 2.92%
- EPS Growth
- EYPT N/A
- ASIX 3682.26
- EPS
- EYPT N/A
- ASIX 3.11
- Revenue
- EYPT $56,042,000.00
- ASIX $1,558,519,000.00
- Revenue This Year
- EYPT N/A
- ASIX $7.41
- Revenue Next Year
- EYPT N/A
- ASIX $4.60
- P/E Ratio
- EYPT N/A
- ASIX $7.05
- Revenue Growth
- EYPT 12.04
- ASIX 6.03
- 52 Week Low
- EYPT $3.91
- ASIX $18.44
- 52 Week High
- EYPT $13.99
- ASIX $33.00
- Technical
- Relative Strength Index (RSI)
- EYPT 59.34
- ASIX 38.00
- Support Level
- EYPT $10.26
- ASIX $21.85
- Resistance Level
- EYPT $11.00
- ASIX $22.79
- Average True Range (ATR)
- EYPT 0.64
- ASIX 0.68
- MACD
- EYPT -0.07
- ASIX -0.15
- Stochastic Oscillator
- EYPT 42.11
- ASIX 10.45
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
About ASIX AdvanSix Inc.
AdvanSix Inc. is a diversified chemistry company playing a critical role in globally supply chains, innovating and delivering essential products for customers in a wide variety of end markets and applications that touch people's lives, such as building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives and electronics. The company key products includes: Nylon, Caprolactam, Plant Nutrients, and Chemical Intermediates The majority of sales is from Plant Nutrients products.